These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11804072)

  • 21. Severe symptomatic hyponatremia during citalopram therapy.
    Odeh M; Beny A; Oliven A
    Am J Med Sci; 2001 Feb; 321(2):159-60. PubMed ID: 11217819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of reboxetine and citalopram on hand-motor function in patients suffering from major depression.
    Hegerl U; Mergl R; Henkel V; Pogarell O; Müller-Siecheneder F; Frodl T; Juckel G
    Psychopharmacology (Berl); 2005 Feb; 178(1):58-66. PubMed ID: 15316714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-methyl-citalopram: A quaternary selective serotonin reuptake inhibitor.
    Bismuth-Evenzal Y; Roz N; Gurwitz D; Rehavi M
    Biochem Pharmacol; 2010 Nov; 80(10):1546-52. PubMed ID: 20696140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent hyponatremia after substitution of citalopram with duloxetine.
    Dirks AC; van Hyfte DM
    J Clin Psychopharmacol; 2007 Jun; 27(3):313. PubMed ID: 17502788
    [No Abstract]   [Full Text] [Related]  

  • 25. Citalopram-Induced Galactorrhea in an Adolescent.
    Türkoğlu S
    Clin Neuropharmacol; 2016; 39(6):331. PubMed ID: 27438185
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical implications of directly switching antidepressants in well-treated depressed patients with treatment-emergent sexual dysfunction: a comparison between vortioxetine and escitalopram.
    Jacobsen PL; Nomikos GG; Zhong W; Cutler AJ; Affinito J; Clayton A
    CNS Spectr; 2020 Feb; 25(1):50-63. PubMed ID: 31010445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous vasculitis during selective serotonin reuptake inhibitor therapy.
    Flores-Suárez LF; Vega-Memije ME; Chanussot-Deprez C
    Am J Med; 2006 Oct; 119(10):e1-3. PubMed ID: 17000205
    [No Abstract]   [Full Text] [Related]  

  • 28. [Diagnosis of epilepsy complicated by panic disorder and a non-specific reaction to a SSRI].
    Wanders AJ; de Leeuw AS; van Megen HJ
    Tijdschr Psychiatr; 2010; 52(5):349-52. PubMed ID: 20458682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopram.
    Markowitz JS; DeVane CL; Liston HL; Montgomery SA
    Int Clin Psychopharmacol; 2000 Nov; 15(6):329-33. PubMed ID: 11110008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Escitalopram.
    Aronson S; Delgado P
    Drugs Today (Barc); 2004 Feb; 40(2):121-31. PubMed ID: 15045034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Serotonin "Cocktail".
    Nunes JC; Botas JL
    Prim Care Companion CNS Disord; 2020 Jul; 22(4):. PubMed ID: 32628370
    [No Abstract]   [Full Text] [Related]  

  • 32. The precipitation of mania by citalopram in a patient with interferon-induced depression.
    Beckwith AR
    Psychosomatics; 2008; 49(4):362-3. PubMed ID: 18621943
    [No Abstract]   [Full Text] [Related]  

  • 33. Citalopram related euprolactinaemic galactorrhoea: a case report.
    Belli H; Vardar MK; Yesilyurt S; Gul ES; Ural C
    West Indian Med J; 2010 Jan; 59(1):100-1. PubMed ID: 20931925
    [No Abstract]   [Full Text] [Related]  

  • 34. [Citalopram is not safe from the cardiac point of view--SSRI preparations can cause prolonged QTc time].
    Odar-Cederlöf I; Hjelmström P; Jersenius I; Andersson M; Rasmanis G; Bergman U
    Lakartidningen; 2006 Apr 5-11; 103(14):1112-4. PubMed ID: 16681095
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hypertension induced by escitalopram].
    Korkmaz S; Korkmaz H
    Turk Psikiyatri Derg; 2011; 22(1):61. PubMed ID: 21416744
    [No Abstract]   [Full Text] [Related]  

  • 36. Sex differences in depressive symptoms and tolerability after treatment with selective serotonin reuptake inhibitor antidepressants: Secondary analyses of the GENPOD trial.
    Gougoulaki M; Lewis G; Nutt DJ; Peters TJ; Wiles NJ; Lewis G
    J Psychopharmacol; 2021 Aug; 35(8):919-927. PubMed ID: 33637001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Citalopram-induced serotonin syndrome: a case report.
    Tseng WP; Tsai JH; Wu MT; Huang CT; Liu HW
    Kaohsiung J Med Sci; 2005 Jul; 21(7):326-8. PubMed ID: 16089311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sexsomnia during treatment with a selective serotonin reuptake inhibitor].
    Krol DG
    Tijdschr Psychiatr; 2008; 50(11):735-9. PubMed ID: 18991234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study.
    Maljuric NM; Noordam R; Aarts N; Niemeijer MN; van den Berg ME; Hofman A; Kors JA; Stricker BH; Visser LE
    Br J Clin Pharmacol; 2015 Oct; 80(4):698-705. PubMed ID: 25966843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
    Strawn JR; Mills JA; Croarkin PE
    J Child Adolesc Psychopharmacol; 2019 May; 29(4):250-255. PubMed ID: 30810350
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.